FORT COLLINS, Colo. – September 18, 2013 – Ventria Bioscience has been selected from among more than 60 applicants to present at the 3rd annual Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), spearheaded by the Colorado BioScience Association (CBSA) in collaboration with associations in Arizona, Montana, New Mexico and Utah. The selection committee chose Ventria Bioscience, along with other regional life science companies, to present to more than 50 national investors and strategic partners on September 18 and 19, 2013 at The Ritz-Carlton in Denver.
“As we enter into the third RMLIPC we are thrilled by the amount of talent that calls the Rocky Mountain region home,” said April Giles, president and CEO of CBSA. “With over 60 total company applications, we have chosen the top 30 technologies. It is important for us to showcase the best companies Colorado and the surrounding region have to offer to investors from the rest of the country. We are again pleased to announce that Johnson & Johnson Development Corporation is the Founding Partner for the conference."
Ventria Bioscience will present a brief overview of its technology, product pipeline, and plans for growth on September 19 at 9:15 am in the Fall River I room.
“Ventria Bioscience has experienced a great deal of growth and evolution in our product pipeline and a maturation of our business objectives,” said Scott Deeter, president and CEO of Ventria Bioscience. “We view the conference as an opportunity to share our company’s prospects and technology with potential strategic partners, investors, and the local life science community.”
For more information and registration details, visit www.RockyMtnBioInvest.com.
Ventria Bioscience develops, manufactures, and markets biotherapeutics and bioreagents. Ventria Bioscience’s patented ExpressTec biomanufacturing technology enables the development of new and cost-effective biologic products. For more information, visit www.Ventria.com.
The CBSA is a not-for-profit organization providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to promote the growth of the industry by advocating for a better business environment, growing the state's biotech workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on behalf of the industry. For more information, visit www.cobioscience.com.